CAS 792184-90-8

Formula: C20H17FN8

InChI: InChI=1S/C20H17FN8/c21-14-7-9-16(10-8-14)26-20-28-18(24-13-17-22-11-4-12-23-17)27-19(29-20)25-15-5-2-1-3-6-15/h1-12H,13H2,(H3,24,25,26,27,28,29)

InChI key: APYUZVKHUKMAIJ-UHFFFAOYSA-N

SMILES: C1=CC=C(C=C1)NC2=NC(=NC(=N2)NCC3=NC=CC=N3)NC4=CC=C(C=C4)F

N2-(4-Fluorophenyl)-N4-phenyl-N6-(pyrimidin-2-ylmethyl)-1,3,5-triazine-2,4,6-triamine

CAS: 792184-90-8

Purity: 98%

Ref: IN-DA01V3SU

ASP2905

CAS: 792184-90-8

ASP2905

Formula: C₂₀H₁₇FN₈

Purity: ≥95%

Molecular weight: 388.4

Ref: 54-BUP03857

ASP2905

CAS: 792184-90-8

N2-(4-Fluorophenyl)-N4-phenyl-N6-(pyrimidin-2-ylmethyl)-1,3,5-triazine-2,4,6-triamine

Formula: C₂₀H₁₇FN₈

Purity: 99%

Molecular weight: 388.4

Ref: IN-DG01427868

ASP2905

CAS: 792184-90-8

ASP-2905 is a potent and selective inhibitor of potassium channel Kv12.2 encoded by the Kcnh3/BEC1 gene.

Formula: C₂₀H₁₇FN₈

Purity: 97.29% - 99.78%

Color and Shape: White Solid

Molecular weight: 388.4

Ref: TM-T9070

ASP2905

CAS: 792184-90-8

ASP2905 is a drug candidate that has been shown to attenuate the symptoms of Alzheimer's disease in mice. It is an orally active compound that binds to the virus's RNA and prevents it from replicating. ASP2905 also inhibits the production of amyloid beta, which are proteins that are believed to be responsible for the development of Alzheimer's disease. ASP2905 has been found to be effective against neuropharmacological disorders in neonatal mice, such as hyperlocomotion. The drug was also found to be effective at mitigating the effects of Parkinson's disease in knockout mice when administered at an effective dose.

Formula: C₁₄H₁₃Cl₂NO

Purity: Min. 95%

Molecular weight: 282.2 g/mol

Ref: 3D-SGB18490